Ceva Animal health has introduced Marbox, a broad-spectrum anti-infective for the rapid treatment of bovine mastitis and respiratory disorders.
Ceva Animal health has introduced Marbox, a broad-spectrum anti-infective, based on marbofloxacin, for the rapid treatment of bovine mastitis and respiratory disorders.
Marbox effectively provides two products in one bottle because it can be used as a high dose single injection for the treatment of respiratory infection or used for the treatment of acute mastitis; intravenously for the first injection and then subcutaneously at a lower dose over three days. It has a milk withdrawal of just 36 hours after subcutaneous injection.
Mastitis and respiratory disorders currently account for around 60% of antimicrobial prescriptions.
Marbox is presented in an ergonomic CLAS vial which makes for light and shock-resistant handling, resulting in fewer breakages and reduced costs. It is available in 100 and 250 vial sizes and contains 100mg marbofloxacin per ml.
Marbox can be used in combination with Meloxidyl, Ceva’s new, single shot anti-inflammatory. The product joins Ceva’s popular bovine range of anti-infectives, which includes Cevaxel®, Florkem® and Spectam® Injectable.
For further product information contact CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, telephone 01494 781510 or visit the website at www.ceva.uk.com